Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)
$0.7198
+0.0008 ( +0.11% ) 62.8K
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Market Data
Open
$0.7198
Previous close
$0.7190
Volume
62.8K
Market cap
$3.51M
Day range
$0.6680 - $0.7230
52 week range
$0.3625 - $8.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Dec 07, 2023 |
| pre | Proxies and info statements | 4 | Nov 21, 2023 |
| 8-k | 8K-related | 14 | Nov 17, 2023 |
| 8-k | 8K-related | 14 | Nov 17, 2023 |
| 8-k | 8K-related | 14 | Nov 16, 2023 |
| nt | Quarterly Reports | 1 | Nov 15, 2023 |
| 8-k | 8K-related | 12 | Oct 11, 2023 |
| 3 | Insider transactions | 2 | Oct 03, 2023 |
| 8-k | 8K-related | 14 | Sep 05, 2023 |
| 8-k | 8K-related | 13 | Aug 16, 2023 |